Ubiquitination in the regulation of inflammatory cell death and cancer

被引:284
作者
Cockram, Peter E. [1 ,2 ]
Kist, Matthias [3 ]
Prakash, Sumit [1 ]
Chen, Si-Han [1 ]
Wertz, Ingrid E. [1 ,3 ]
Vucic, Domagoj [3 ]
机构
[1] Genentech Inc, Dept Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Discovery Chem, 1 DNA Way, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA
关键词
NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; PROTEASOME INHIBITOR MLN9708; A20 RESTRICTS UBIQUITINATION; CORONAVIRUS PAPAIN-LIKE; TNF RECEPTOR 1; LINEAR UBIQUITIN; NLRP3; INFLAMMASOME; ANTAGONISTS INDUCE; CASPASE ACTIVATION;
D O I
10.1038/s41418-020-00708-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin system is complex, multifaceted, and is crucial for the modulation of a vast number of cellular processes. Ubiquitination is tightly regulated at different levels by a range of enzymes including E1s, E2s, and E3s, and an array of DUBs. The UPS directs protein degradation through the proteasome, and regulates a wide array of cellular processes including transcription and epigenetic factors as well as key oncoproteins. Ubiquitination is key to the dynamic regulation of programmed cell death. Notably, the TNF signaling pathway is controlled by competing ubiquitin conjugation and deubiquitination, which governs both proteasomal degradation and signaling complex formation. In the inflammatory response, ubiquitination is capable of both activating and dampening inflammasome activation through the control of either protein stability, complex formation, or, in some cases, directly affecting receptor activity. In this review, we discuss the enzymes and targets in the ubiquitin system that regulate fundamental cellular processes regulating cell death, and inflammation, as well as disease consequences resulting from their dysregulation. Finally, we highlight several pre-clinical and clinical compounds that regulate ubiquitin system enzymes, with the aim of restoring homeostasis and ameliorating diseases.
引用
收藏
页码:591 / 605
页数:15
相关论文
共 195 条
  • [1] Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
    Aggarwal, Bharat B.
    Gupta, Subash C.
    Kim, Ji Hye
    [J]. BLOOD, 2012, 119 (03) : 651 - 665
  • [2] Ubiquitin chain diversity at a glance
    Akutsu, Masato
    Dikic, Ivan
    Bremm, Anja
    [J]. JOURNAL OF CELL SCIENCE, 2016, 129 (05) : 875 - 880
  • [3] Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways
    Allegra, Alessandro
    Speciale, Antonio
    Molonia, Maria Sofia
    Guglielmo, Letterio
    Musolino, Caterina
    Ferlazzo, Guido
    Costa, Gregorio
    Saija, Antonella
    Cimino, Francesco
    [J]. TOXICOLOGY IN VITRO, 2018, 47 : 186 - 194
  • [4] Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis
    Amin, Palak
    Florez, Marcus
    Najafov, Ayaz
    Pan, Heling
    Geng, Jiefei
    Ofengeim, Dimitry
    Dziedzic, Slawomir A.
    Wang, Huibing
    Barrett, Vica Jean
    Ito, Yasushi
    LaVoie, Matthew J.
    Yuan, Junying
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (26) : E5944 - E5953
  • [5] Mechanism of processing of the NF-κB2 p100 precursor:: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase
    Amir, RE
    Haecker, H
    Karin, M
    Ciechanover, A
    [J]. ONCOGENE, 2004, 23 (14) : 2540 - 2547
  • [6] Proteasome Inhibitors Impair RANKL-Induced NF-κB Activity in Osteoclast-Like Cells Via Disruption of p62, TRAF6, CYLD, and IκBα Signaling Cascades
    Ang, Estabelle
    Pavlos, Nathan J.
    Rea, Sarah L.
    Qi, Ming
    Chai, Tracy
    Walsh, John P.
    Ratajczak, Thomas
    Zheng, Ming H.
    Xu, Jiake
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 220 (02) : 450 - 459
  • [7] Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2
    Annibaldi, Alessandro
    John, Sidonie Wicky
    Berghe, Tom Vanden
    Swatek, Kirby N.
    Ruan, Jianbin
    Liccardi, Gianmaria
    Bianchi, Katiuscia
    Elliott, Paul R.
    Choi, Sze Men
    Van Coillie, Samya
    Bertin, John
    Wu, Hao
    Komander, David
    Vandenabeele, Peter
    Silke, John
    Meier, Pascal
    [J]. MOLECULAR CELL, 2018, 69 (04) : 566 - +
  • [8] Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
    Annunziata, Christina M.
    Davis, R. Eric
    Demchenko, Yulia
    Bellamy, William
    Gabrea, Ana
    Zhan, Fenghuang
    Lenz, Georg
    Hanamura, Ichiro
    Wright, George
    Xiao, Wenming
    Dave, Sandeep
    Hurt, Elaine M.
    Tan, Bruce
    Zhao, Hong
    Stephens, Owen
    Santra, Madhumita
    Williams, David R.
    Dang, Lenny
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    Kuehl, W. Michael
    Staudt, Louis M.
    [J]. CANCER CELL, 2007, 12 (02) : 115 - 130
  • [9] X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
    Baez-Santos, Yahira M.
    Barraza, Scott J.
    Wilson, Michael W.
    Agius, Michael P.
    Mielech, Anna M.
    Davis, Nicole M.
    Baker, Susan C.
    Larsen, Scott D.
    Mesecar, Andrew D.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2393 - 2412
  • [10] Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
    Baud, V
    Liu, ZG
    Bennett, B
    Suzuki, N
    Xia, Y
    Karin, M
    [J]. GENES & DEVELOPMENT, 1999, 13 (10) : 1297 - 1308